Srinivasa Rao Nagalla
Fondateur chez DiabetOmics, Inc.
Profil
Srinivasa Rao Nagalla is the founder.
He founded ProteoGenix, Inc. in 2002, where he held the title of Director, Chief Scientific Officer, EVP & Co-Founder in 2009.
He also founded DiabetOmics, Inc. in 2008 and currently holds the title of President, Chief Executive Officer & Director.
In addition to his founding positions, Dr. Nagalla has held former job positions.
He worked as an Associate Professor at Oregon Health & Science University and as a Principal at the National Institutes of Health.
Dr. Nagalla obtained his doctorate degree from All India Institute of Medical Sciences.
Postes actifs de Srinivasa Rao Nagalla
| Sociétés | Poste | Début |
|---|---|---|
DiabetOmics, Inc.
 DiabetOmics, Inc. Medical/Nursing ServicesHealth Services DiabetOmics, Inc. provides diabetes care services. It engages in the non-invasive assessment and management of personalized health and diabetes risk, progression and complications. The firm?s services include personalized wellness profile with laboratory tests, action plan for disease prevention and identifying conditions that may be present before symptoms occur. The company was founded by Srinivasa Rao Nagalla, Paturi V. Rao and Charles Roberts in 2008 and is headquartered in Hillsboro, OR. | Fondateur | 01/01/2008 |
Anciens postes connus de Srinivasa Rao Nagalla
| Sociétés | Poste | Fin |
|---|---|---|
| Oregon Health & Science University | Corporate Officer/Principal | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
ProteoGenix, Inc.
 ProteoGenix, Inc. Medical SpecialtiesHealth Technology ProteoGenix is the first and only company solely committed to developing minimally invasive diagnostics that address unmet medical needs and improve pregnancy and neonatal management and outcomes. By applying innovative proteomic and molecular technologies, ProteoGenix has quickly become a leader in developing powerful diagnostic tools that have the potential to dramatically change the future of pregnancy and neonatal management. In 2002, four leading researchers in the area of perinatology and neonatology joined together to create ProteoGenix, a company dedicated to solving the mysteries of preterm birth and the significant medical, emotional and economic consequences that prematurity has on their society. Their passion for improving pregnancy management and the outcomes associated with preterm birth, along with their clinical expertise and scientific acumen, led ProteoGenix to achieve a truly significant recent scientific discovery identification of The Proteomic Map of Pregnancy. The physicians and scientists that became ProteoGenix were the first to identify and characterize a fundamental map of the key biologic fluids in pregnancy and show how this landscape changes in important pregnancy-related disorders. This groundbreaking work has received several significant scientific awards, including Best Clinical Study at the 2007 annual meeting of the Society for Maternal-Fetal Medicine, and has been the topic of numerous peer-reviewed publications. ProteoGenix has also developed the unique capability to utilize sophisticated nucleic acid-based molecular microbiology techniques such as quantitative Polymerase Chain Reaction (PCR) and Pyrosequencing, specifically optimized for use in key maternal, fetal, neonatal biological fluids to detect infectious and path physiological diseases associated with pregnancy. | Directeur Général | - |
Formation de Srinivasa Rao Nagalla
| All India Institute of Medical Sciences | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
ProteoGenix, Inc.
ProteoGenix, Inc. Medical SpecialtiesHealth Technology ProteoGenix is the first and only company solely committed to developing minimally invasive diagnostics that address unmet medical needs and improve pregnancy and neonatal management and outcomes. By applying innovative proteomic and molecular technologies, ProteoGenix has quickly become a leader in developing powerful diagnostic tools that have the potential to dramatically change the future of pregnancy and neonatal management. In 2002, four leading researchers in the area of perinatology and neonatology joined together to create ProteoGenix, a company dedicated to solving the mysteries of preterm birth and the significant medical, emotional and economic consequences that prematurity has on their society. Their passion for improving pregnancy management and the outcomes associated with preterm birth, along with their clinical expertise and scientific acumen, led ProteoGenix to achieve a truly significant recent scientific discovery identification of The Proteomic Map of Pregnancy. The physicians and scientists that became ProteoGenix were the first to identify and characterize a fundamental map of the key biologic fluids in pregnancy and show how this landscape changes in important pregnancy-related disorders. This groundbreaking work has received several significant scientific awards, including Best Clinical Study at the 2007 annual meeting of the Society for Maternal-Fetal Medicine, and has been the topic of numerous peer-reviewed publications. ProteoGenix has also developed the unique capability to utilize sophisticated nucleic acid-based molecular microbiology techniques such as quantitative Polymerase Chain Reaction (PCR) and Pyrosequencing, specifically optimized for use in key maternal, fetal, neonatal biological fluids to detect infectious and path physiological diseases associated with pregnancy. | Health Technology |
DiabetOmics, Inc.
DiabetOmics, Inc. Medical/Nursing ServicesHealth Services DiabetOmics, Inc. provides diabetes care services. It engages in the non-invasive assessment and management of personalized health and diabetes risk, progression and complications. The firm?s services include personalized wellness profile with laboratory tests, action plan for disease prevention and identifying conditions that may be present before symptoms occur. The company was founded by Srinivasa Rao Nagalla, Paturi V. Rao and Charles Roberts in 2008 and is headquartered in Hillsboro, OR. | Health Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
